Over the last 7 days, the Biotech industry has dropped 1.1%, driven by declines in Vertex Pharmaceuticals and Amgen of 5.3% and 3.4%, respectively. In the past year, the industry has gained 9.3%. Looking forward, earnings are forecast to grow by 31% annually.
Has the U.S. Biotech Industry valuation changed over the past few years?
Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
---|---|---|---|---|---|---|
Sun, 11 Aug 2024 | US$856.5b | US$112.6b | -US$37,136,901,661.41 | 21.6x | -23.1x | 7.6x |
Tue, 09 Jul 2024 | US$1.1t | US$164.5b | -US$28,072,591,965.78 | 28.2x | -40.3x | 6.9x |
Thu, 06 Jun 2024 | US$1.1t | US$164.6b | -US$26,649,807,121.82 | 28.1x | -42.6x | 6.9x |
Sat, 04 May 2024 | US$1.1t | US$163.7b | -US$26,731,775,868.34 | 24.3x | -41.9x | 6.8x |
Mon, 01 Apr 2024 | US$1.2t | US$164.4b | -US$23,612,220,177.66 | 24x | -50x | 7.2x |
Wed, 28 Feb 2024 | US$1.2t | US$167.3b | -US$21,469,811,290.45 | 13.8x | -55.3x | 7.1x |
Fri, 26 Jan 2024 | US$1.4t | US$204.7b | -US$22,591,368,127.00 | 18.5x | -63.1x | 7x |
Sun, 24 Dec 2023 | US$1.4t | US$204.9b | -US$22,149,017,627.00 | 19.4x | -61.9x | 6.7x |
Tue, 21 Nov 2023 | US$1.2t | US$204.7b | -US$22,041,856,134.00 | 18.1x | -55.4x | 6x |
Thu, 19 Oct 2023 | US$1.3t | US$207.3b | -US$13,074,578,847.00 | 17.1x | -95.7x | 6x |
Sat, 16 Sep 2023 | US$1.3t | US$207.5b | -US$12,636,400,679.00 | 17.6x | -101.2x | 6.2x |
Mon, 14 Aug 2023 | US$1.3t | US$207.7b | -US$12,468,580,885.00 | 16.6x | -103.3x | 6.2x |
Wed, 12 Jul 2023 | US$1.1t | US$186.4b | -US$16,009,595,226.00 | 13.3x | -70.2x | 6x |
Fri, 09 Jun 2023 | US$1.2t | US$186.1b | -US$15,982,663,871.00 | 11.8x | -72x | 6.2x |
Sun, 07 May 2023 | US$1.2t | US$192.6b | -US$12,085,119,722.00 | 15.6x | -97.1x | 6.1x |
Tue, 04 Apr 2023 | US$1.2t | US$217.1b | -US$5,977,015,471.00 | 14.3x | -194.8x | 5.4x |
Thu, 02 Mar 2023 | US$1.1t | US$199.1b | -US$5,117,523,678.00 | 15.3x | -222.5x | 5.7x |
Sat, 28 Jan 2023 | US$1.2t | US$203.8b | US$1.8b | 14.8x | 668.4x | 5.7x |
Mon, 26 Dec 2022 | US$1.2t | US$203.3b | US$1.6b | 14.5x | 703x | 5.7x |
Wed, 23 Nov 2022 | US$1.1t | US$202.1b | US$1.2b | 14.9x | 926.5x | 5.6x |
Fri, 21 Oct 2022 | US$1.0t | US$206.2b | US$5.5b | 15.6x | 188.5x | 5x |
Sun, 18 Sep 2022 | US$1.1t | US$206.6b | US$5.8b | 14.7x | 184.6x | 5.2x |
Tue, 16 Aug 2022 | US$1.1t | US$206.7b | US$7.2b | 16x | 157x | 5.5x |
Thu, 14 Jul 2022 | US$1.1t | US$211.3b | US$10.7b | 17.3x | 101.6x | 5.1x |
Sat, 11 Jun 2022 | US$957.4b | US$212.3b | US$11.1b | 15.6x | 86.5x | 4.5x |
Mon, 09 May 2022 | US$989.9b | US$207.7b | US$9.7b | 14.1x | 102.2x | 4.8x |
Wed, 06 Apr 2022 | US$1.3t | US$226.9b | US$14.4b | 18.8x | 90x | 5.7x |
Fri, 04 Mar 2022 | US$1.2t | US$223.3b | US$8.7b | 19.6x | 141x | 5.5x |
Sun, 30 Jan 2022 | US$1.2t | US$212.2b | US$2.5b | 23x | 492x | 5.8x |
Tue, 28 Dec 2021 | US$1.4t | US$212.0b | US$2.8b | 26x | 515.3x | 6.8x |
Thu, 25 Nov 2021 | US$1.4t | US$211.8b | US$3.2b | 25.7x | 455.6x | 6.8x |
Sat, 23 Oct 2021 | US$1.5t | US$196.3b | -US$2,788,794,019.00 | 24x | -530.7x | 7.5x |
Mon, 20 Sep 2021 | US$1.6t | US$196.3b | -US$2,228,284,348.00 | 25.6x | -715.8x | 8.1x |
Wed, 18 Aug 2021 | US$1.5t | US$197.0b | -US$1,662,914,785.58 | 22.4x | -929.7x | 7.8x |
-929.7x
Which industries have driven the changes within the U.S. Healthcare industry?
US Market | 0.13% | |
Healthcare | -0.34% | |
Biotech | -1.10% | |
Biotech | -1.10% |
Which companies have driven the market over the last 7 days?
Company | Last Price | 7D | 1Y | Valuation | |
---|---|---|---|---|---|
REGN Regeneron Pharmaceuticals | US$1.13k | 4.5% +US$5.3b | 40.2% | PE28.3x | |
BGNE BeiGene | US$182.76 | 12.0% +US$2.1b | -7.5% | PS6.3x | |
SGEN Seagen | US$228.74 | 4.5% +US$1.8b | 76.5% | PS18.8x | |
NTRA Natera | US$114.57 | 15.0% +US$1.8b | 103.8% | PS10.3x | |
ABBV AbbVie | US$189.93 | 0.3% +US$1.2b | 24.8% | PE63.3x |